Press release
Press Release: Intravenous Immunoglobulin Market Experiences Robust Growth Driven by Rising Demand for Immunodeficiency Treatments
Intravenous Immunoglobulin (IVIG) Market
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2728
Key Drivers of Market Growth
One of the primary factors driving the IVIG market is the increasing prevalence of immunodeficiency disorders worldwide. Immunodeficiency disorders, including primary and secondary forms, affect millions of individuals globally. Notably, secondary immunodeficiency, often caused by HIV, impacts over 39 million people according to the World Health Organization (WHO). The growing aging population, the increasing incidence of chronic diseases such as diabetes and obesity, and the use of immunosuppressive drugs are also contributing to the surge in immunodeficiency cases.
Additionally, the healthcare industry's ongoing investment in technology has enabled the development of more advanced IVIG therapies. Emerging technologies such as nanoparticle-based IVIG, plant-derived IVIG, and formulations with reduced side effects are improving treatment outcomes for a range of immune-related conditions. These technological innovations are expected to contribute to market growth in the coming years.
Product Launches and Technological Advancements
Several leading companies are launching innovative IVIG products, further propelling market growth. For instance, Biotest AG recently introduced Yimmugo (IgG Next Generation), a sugar-free, ready-to-use solution designed to treat both primary and secondary immune deficiencies. This product exemplifies the industry's commitment to enhancing treatment options for patients with immune-related diseases.
New IVIG formulations, along with the increasing availability of home infusion services, are making treatments more accessible and patient-friendly. Home-based IVIG therapies allow patients to receive care in the comfort of their own homes, improving their quality of life.
Challenges Facing the Market
Despite the market's promising growth, several challenges remain. The high cost of IVIG therapy is a significant barrier, particularly in low- and middle-income countries where reimbursement policies are limited. The rising demand for IVIG treatments has also led to higher drug prices, putting additional financial strain on patients and healthcare systems.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2728
Segment Insights
Product Types: IgG Leads the Market
The IVIG market is segmented by product types, including IgA, IgM, IgG, IgE, and IgD. Among these, the IgG segment held the largest market share in 2022, owing to its effectiveness in treating autoimmune and inflammatory diseases. According to the National Stem Cell Foundation, 4% of the global population is affected by autoimmune diseases such as multiple sclerosis and type 1 diabetes, driving demand for IgG-based treatments.
Applications: Primary Immunodeficiency Disorders Dominate
The application segment includes various diseases treated by IVIG, such as primary immunodeficiency diseases, Myasthenia Gravis, and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). The primary immunodeficiency disease segment accounted for the largest market share in 2022. With around 6 million people globally affected by primary immunodeficiencies, the need for IVIG therapies is substantial.
End-Use: Hospitals Remain Key Players
Hospitals are the primary end-users of IVIG therapies, holding the largest market share in 2022. Hospitals offer specialized care for patients with immunodeficiency disorders and provide the necessary facilities for safe and effective administration of IVIG treatments. Clinics and homecare settings are also growing segments, driven by the increasing availability of home infusion services.
Intravenous Immunoglobulin (IVIG) Top Companies and Competitive Landscape
The global intravenous immunoglobulin market is fairly fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective intravenous immunoglobulin market.
Some major players included in the global intravenous immunoglobulin market report are:
Baxter
Pfizer Inc.
Johnson and Johnson Private limited
Takeda Pharmaceutical company Limited
Grifols,S.A
CSL
Biotest AG
Octapharma
Bio Products Laboratory Limited
LFB
Intravenous Immunoglobulin (IVIG) Latest Industry Updates
On 18 April 2023, CSL Behring announced approval of S. Food and Drug Administration (FDA) approved prefilled syringe for Hizentra. The prefilled syringes are for individuals living with living with Primary Immunodeficiency (PI) or Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This Immune Globulin (Ig) is available in a simple, convenient and ready-to-use prefilled syringe. This announcement reinforces CSL Behring commitment to providing patients by eliminating the need for hospital-administered infusion with their new prefilled syringes. and treatment in the field of immunodeficiency disease.
On 25 September 2023, Biogen announced LEQMBI LEQEMBI is a humanized Immunoglobulin Gamma 1(IgG1) monoclonal antibody provides initial treatment of patients with Alzheimer's and represents another high-value product for our growing in immunodeficiency disease treatment. This announcement adds Biogen line-up of eliminating the need for the need for hospital-administered infusions, empowering patients to self-administer their medication from the comfort of their own homes.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2728
For the purpose of this report, Emergen Research has segmented the global intravenous immunoglobulin market on the basis of type, application, route of administration, end-use, and region:
Type Outlook (Revenue, USD Billion; 2019-2032)
IgA
IgM
IgD
IgE
IgG
Route of administration (Revenue, USD Billion; 2019-2032)
Intravenous
Subcutaneous
Application Outlook (Revenue, USD Billion; 2019-2032)
Primary Immunodeficiency Diseases
Myasthenia Gravis
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Hypogammaglobulinemia
Multifocal motor neuropathy
Kawasaki Disease
Guillain-barre Syndrome
Others
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Clinics
Homecare
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Look Over transcripts provided by Emergen Research
Intravenous Immunoglobulin (IVIG) Market Size@ https://www.emergenresearch.com/industry-report/intravenous-immunoglobulin-market/market-size
Intravenous Immunoglobulin (IVIG) Market Share@ https://www.emergenresearch.com/industry-report/intravenous-immunoglobulin-market/market-share
Intravenous Immunoglobulin (IVIG) Market Trends@ https://www.emergenresearch.com/industry-report/intravenous-immunoglobulin-market/market-trends
Intravenous Immunoglobulin (IVIG) Regional Market Demand@ https://www.emergenresearch.com/industry-report/intravenous-immunoglobulin-market/regional-market-demand
Intravenous Immunoglobulin (IVIG) Market Analysis@ https://www.emergenresearch.com/industry-report/intravenous-immunoglobulin-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Press Release: Intravenous Immunoglobulin Market Experiences Robust Growth Driven by Rising Demand for Immunodeficiency Treatments here
News-ID: 3687122 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends…
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,…
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary research…
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the…
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from…
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog …
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the company’s strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course of…
